Atara Biotherapeutics, Inc (ATRA) Stock Price

ATRAStock
$9.8423.34%52W
Market Cap$98.77M
P/E2.61x
PEG Ratio
Div yield
Beta0.22

ATRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)102.30%
Price vs S&P 500 (4W)18.07%
VGM Score38.25
P/E Ratio (Annual)2.61x

ATRA Earnings Surprise History

Q2 250.19est. -0.32
Q3 25-0.32est. -0.67
Q4 25-0.35est. -0.10
Q2 26-0.32est. -0.25

ATRA Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.80
4.00
4.00
4.00

Industry Peers — Biological Products(183)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ATRAAtara Biotherapeutics, Inc
CFC$9.84
AMGNAmgen IncCCB$442.24
GILDGilead Sciences IncCBB$148.77
MRNAModerna, Inc. Common StockDCA$158.83
ARGXargenx SE American Depositary SharesDAB$1019.49
RVMDRevolution Medicines, Inc. Common StockFA$211.38
BIIBBiogen Inc. Common StockCDB$220.77
BNTXBioNTech SE American Depositary ShareCCB$114.05
NBIXNeurocrine Biosciences IncCBC$153.37
EXELExelixis IncCBB$56.72
HALOHalozyme Therapeutics, Inc.CBA$109.32

About Atara Biotherapeutics, Inc

Atara Biotherapeutics develops cell therapies targeting serious diseases including solid tumors, hematologic cancers, and autoimmune disorders. The company's CAR T platform includes product candidates Tab-cel, ATA188, and ATA3219 in its development pipeline.